Insights of Sickle Cell Disease : Pipeline Review, Development and Forecast 2017-2021
ResearchMoz presents professional and in-depth study of "Sickle Cell Disease - Pipeline Review, H1 2017". Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease - Pipeline Review, H1 2017, provides an overview of the Sickle Cell Disease (Hematological Disorders) pipeline landscape. Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. Treatment includes antibiotics, pain relievers, blood transfusion and stem cell transplant. Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Sickle Cell Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Sickle Cell Disease (Hematological Disorders), complete with analysis by stage of development, dru...